Nov 23, 2017Inflection Biosciences and RCSI Enter Research Collaboration to Target Therapy Resistant Breast CancDublin, Ireland, November 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, and RCSI (Royal College of ...
Nov 2, 2017Inflection Biosciences to Present at Investor Conferences in November 2017Dublin, Ireland, November 2, 2017 Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced that the compa...
Jun 22, 2017Inflection Biosciences Announces Pre-clinical Data to be Presented at 2nd EACR-AACR-SIC Special ConfDublin, Ireland, June 23, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced that data on IB...
May 14, 2017Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at IWCLL 2017Dublin, Ireland, May 15th, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced that that new ...
Jan 4, 2017Inflection Biosciences to Present at Biotech Showcase 2017Dublin, Ireland, January 4, 2017 – Inflection Biosciences Ltd, a private company developing innovative therapeutics for cancer, today announced that its Chie...
